Efficacy of Hybrid Vitamin D Receptor Agonist/Histone Deacetylase Inhibitors in Vitamin D-Resistant Triple-Negative 4T1 Breast Cancer.
The Journal of Steroid Biochemistry and Molecular Biology(2018)
摘要
•Bifunctional hybrids containing vitamin D receptor agonist and histone deactylase inhibitor activity are described.•Hybrids are highly antiproliferative against vitamin D-resistant, triple-negative 4T1 breast cancer cells in vitro and in vivo.•Hybrids are efficacious at reducing 4T1 lung metastases.
更多查看译文
关键词
Vitamin D,Histone deacetylase inhibitors,Hybrid molecules,Breast cancer
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要